undamentalytics Newsletter
Sign in

Ironwood Pharmaceuticals Inc revenue

Ironwood Pharmaceuticals Inc's revenue was $296m in fiscal 2025, down 15.7% on the year before. Since fiscal 2009 ($34.3m) it has grown at a compound 14.4% a year. Over the last twelve months it was $389m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue3444661502376150274298347428390414411443351296389
Growth on the year before—+27.8%+50.2%+128.1%−84.8%+234.1%+95.7%+83.2%+8.9%+16.2%+23.6%−9.1%+6.2%−0.8%+7.8%−20.6%−15.7%—
Gross profit———1491671150272279314405386——————
Gross margin———99.4%68.5%93.1%100.0%99.3%93.6%90.6%94.4%99.2%——————

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Collaborative Arrangements $296M 100.0% ▼ 15.7%
Collaborative Arrangement Other Agreements $87,000 0.0% ▼ 88.1%

From Ironwood Pharmaceuticals Inc's 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Ironwood Pharmaceuticals Inc $389m 26.2% -3.1%
Innoviva, Inc. $440m 18.8% 14.9%
Xeris Biopharma Holdings, Inc. $335m 36.3% 35.8%
Evolus, Inc. $316m 13.9% 23.4%
Harrow, Inc. $276m 21.1% 39.0%
Alvotech $586m 19.7% —

Compare with peers

Head to head: INVA vs IRWDIRWD vs XERSEOLS vs IRWD

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Ironwood Pharmaceuticals Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ironwood Pharmaceuticals Inc.